{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:25:05Z","timestamp":1790519105836,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1996,1]]},"abstract":"<jats:p>Chemoembolisation has been extensively used as primary treatment for unresectable hepatocellular carcinoma (HCC). In this unit, 185 patients with a new diagnosis of HCC not amenable to surgery were seen between 1988 and 1991. Intended therapy for these patients was chemoembolisation with doxorubicin (60 mg\/m2) and lipiodol, repeated at six week intervals until it was technically no longer possible or until complete tumour response had been obtained. Chemoembolisation was possible in 67 of the 185 (37%). Reasons for exclusion were portal vein occlusion (n = 36), decompensated cirrhosis (n = 44), distant metastases (n = 5), diffuse tumour or unsuitable anatomy (tumour or vasculature) (n = 11), patient refusal (n = 11), and other (n = 11). Patients excluded from treatment survived for a median of 10 weeks (range 3 days-19 months). In patients treated, 18 had small HCC (&lt; 4 cm) and 49 had large or multifocal HCC. Chemoembolisation was carried out a median of two sessions for small and three sessions for large tumours. Ten of 18 patients with small HCC showed a 50% or greater reduction in tumour size. Five of 49 patients with large or multifocal tumours showed a response to treatment. Median overall survival for treated patients was 36 weeks (range 3 days-4 years). One patient has subsequently undergone liver transplantation with no recurrence and minimal residual disease at transplantation. Two other patients are alive three years after chemoembolisation, one with no evidence of recurrent disease. No patient was thought suitable for surgery after their response to chemoembolisation. Chemotherapy related complications were seen in 22%. Complications were significantly more common in patients with larger tumours and poor liver reserve. Five patients died as a result of chemotherapy related complications. In conclusion, only one third of UK patients with unresectable HCC are treatable by chemoembolisation. Results with small tumours are encouraging, with a high response rate and the possibility of surgical intervention in previously inoperable disease. Large tumours, however, show a poor response and a significant incidence of side effects, suggesting that this treatment offers little benefit in advanced disease.<\/jats:p>","DOI":"10.1136\/gut.38.1.125","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"125-128","source":"Crossref","is-referenced-by-count":44,"title":["Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma."],"prefix":"10.1136","volume":"38","author":[{"given":"S D","family":"Ryder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Metivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Karani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1996,1,1]]},"reference":[{"key":"ref_1","first-page":"100","article-title":"Hepatocellular carcinoma. Postgrad MedJ7","volume":"23","author":"Johnson, P.J.; Williams, R.","year":"1979","unstructured":"Johnson PJ, Williams R. Hepatocellular carcinoma. Postgrad MedJ7 1979; 23: 100-9."},{"key":"ref_2","first-page":"345","article-title":"Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents","volume":"162","author":"Takayashu, K.; Shima, Y.; Muramatsu, Y.; Moriyama, N.; Yamada, T.; Makuuchi, M.","year":"1987","unstructured":"Takayashu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 162: 345-51.","journal-title":"Radiology"},{"key":"ref_3","first-page":"98","article-title":"A 5 year experience of lipiodolization: selective regional chemotherapy","volume":"10","author":"Kanematsu, T.; Furuta, T.; Takenaka, K.; Matsumata, T.; Yoshida, Y.; Nishizaki, T.","year":"1989","unstructured":"Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, et al. A 5 year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102.","journal-title":"Hepatology; with hepatocellular carcinoma"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/1097-0142(19940701)74:1<16::AID-CNCR2820740105>3.0.CO;2-V","article-title":"Transcatheter oily chemoembolization for hepatocellular carcinoma. A four year study of 127 French patients","volume":"74","author":"Bronowicki, J.-P.; Vetter, D.; Dumas, F.; Boudjema, K.; Bader, R.; Weiss, A.-M.","year":"1994","unstructured":"Bronowicki J-P, Vetter D, Dumas F, Boudjema K, Bader R, Weiss A-M, et al. Transcatheter oily chemoembolization for hepatocellular carcinoma. A four year study of 127 French patients. Cancer 1994; 74: 16-22.","journal-title":"Cancer"},{"key":"ref_5","first-page":"965","article-title":"Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture","volume-title":"of cisplatin and ethiodized iol. Gastroenterology 1989; 97","author":"Kasuagi, H.; Kojima, J.; Tatsuta, M.; Okuda, S.; Sasaki, Y.; Imaoka, S.","unstructured":"Kasuagi H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized iol. Gastroenterology 1989; 97: 965-71."},{"key":"ref_6","first-page":"595","article-title":"Therapeutic embolisation of the hepatic artery: a review of 75 procedures","volume":"i:","year":"1985","unstructured":"Allison D, Jordan JH, Hennesy 0. Therapeutic embolisation of the hepatic artery: a review of 75 procedures. Lancet 1985; i: 595-9.","journal-title":"Lancet"},{"key":"ref_7","first-page":"1598","article-title":"Randomized trial of targeted chemotherapy with Lipiodol and 5'-epidoxorubicin compared with symptomatic treatment for hepatoma","volume":"34","author":"Madden, M.V.; Krige, J.E.J.; Bailey, S.; Benningfield, S.J.; Geddes, C.; Werner, I.D.; Terblanche, J.","year":"1994","unstructured":"Madden MV, Krige JEJ, Bailey S, Benningfield SJ, Geddes C, Werner ID, Terblanche J. Randomized trial of targeted chemotherapy with Lipiodol and 5'-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1994; 34: 1598-600.","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF01296419","article-title":"et aL Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma","volume":"37","author":"Farinati, F.; De Maria, N.; Fomasiero, M.; Salvagnini, M.; Fagiuoli, S.; Chiarmonte, M.","year":"1992","unstructured":"Farinati F, De Maria N, Fomasiero M, Salvagnini M, Fagiuoli S, Chiarmonte M, et aL Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma. Dig Dis Sci 1992; 37: 659-62.","journal-title":"Dig Dis Sci"},{"key":"ref_9","first-page":"66","article-title":"Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma","volume":"26","year":"1994","unstructured":"Elba S, Giannuzzi V, Misciagna G, Manghisi 0. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma. Italian Journal of Gastroenterology 1994; 26: 66-8.","journal-title":"Italian Journal of Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0168-8278(05)80138-2","article-title":"Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma","volume":"20","author":"Cerezo, F.I.M.; Tomas, A.; Donoso, L.; Enriquez, J.; Guarner, C.; Balzano, J.","year":"1994","unstructured":"Cerezo FIM, Tomas A, Donoso L, Enriquez J, Guarner C, Balzano J, et al. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma. _J Hepatol 1994; 20: 702-6.","journal-title":"_J Hepatol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1097-0142(19920215)69:4<925::AID-CNCR2820690415>3.0.CO;2-G","article-title":"Percutaneous ethanol injected in the treatment of hepatocellular carcinoma in cirrhosis. A study of 207 patients","volume":"69","author":"Livraghi, T.; Bolondi, L.; Lazzaroni, S.; Marin, G.; Morabito, A.; Rapaccini, G.L.","year":"1992","unstructured":"Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, et al. Percutaneous ethanol injected in the treatment of hepatocellular carcinoma in cirrhosis. A study of 207 patients. Cancer 1992; 69: 925-9.","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1994.tb01207.x","article-title":"Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by arterial chemoembolization","volume":"9","author":"Chen, S.C.; Hsieh, M.Y.; Chuang, W.L.; Wang, L.Y.; Chang, W.Y.","year":"1994","unstructured":"Chen SC, Hsieh MY, Chuang WL, Wang LY, Chang WY. Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by arterial chemoembolization. Jf Gastroenterol Hepatol 1994; 9: 1-6.","journal-title":"Jf Gastroenterol Hepatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hep.1840190508","article-title":"et aL Transcatheter oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors","volume":"19","author":"Mondazzi, L.; Bottelli, R.; Brambilla, G.; Rampoldi, A.; Rezakovic, I.; Zavaglia, C.","year":"1994","unstructured":"Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, et aL Transcatheter oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19: 1115-23.","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0009-9260(05)81446-1","article-title":"Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam","volume":"47","author":"Ngan, H.; Lai, C.L.; Fan, S.T.; Lai, E.C.S.; Yuen, W.K.; Tso, W.K.","year":"1993","unstructured":"Ngan H, Lai CL, Fan ST, Lai ECS, Yuen WK, Tso WK. Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol 1993; 47: 315-20.","journal-title":"Clin Radiol"},{"key":"ref_15","first-page":"2150","article-title":"Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model","volume":"15","author":"Ikeda, K.; Kumada, H.; Saitoshi, S.; Arase, Y.; Chayama, K.","year":"1991","unstructured":"Ikeda K, Kumada H, Saitoshi S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on survival time in patients with hepatocellular carcinoma: an analysis by the Cox proportional hazard model. Cancer 1991; 15: 2150-4.","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"true","year":"1990","unstructured":"Pelletier G, Roche A, Ink 0, Anciaux ML, Derhy S, Rougier P, et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. _J Hepatol 1990; 11: 181-4.","journal-title":"_J Hepatol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199505113321903","article-title":"Traitement du Carcinoma Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","author":"d'Etude et de, Group","year":"1995","unstructured":"Group d'Etude et de Traitement du Carcinoma Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engi _J Med 1995; 332: 1256-61.","journal-title":"N Engi _J Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9610(92)90039-T","article-title":"Primary treatment of hepatocellular carcinoma by arterial chemoembolization","volume":"163","author":"Bismuth, H.; Morino, M.; Sherlock, D.; Castaing, D.; Miglietta, C.; Cauquil, P.","year":"1992","unstructured":"Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am Jf Surg 1992; 163: 387-94.","journal-title":"Am Jf Surg"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/hep.1840160314","article-title":"Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial","volume":"16","author":"Yoshimi, F.; Nagao, T.; Inoue, S.; Kawano, N.; Muto, T.; Gunji, T.","year":"1992","unstructured":"Yoshimi F, Nagao T, Inoue S, Kawano N, Muto T, Gunji T, et al. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatology 1992; 16: 702-6.","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1097-0142(19930101)71:1<62::AID-CNCR2820710111>3.0.CO;2-8","article-title":"Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma","volume":"71","author":"Yu, Y.-Q.; Xu, D.-B.; Zhou, X.-D.; Lu, J.-Z.; Tang, Z.-Y.; Mack, P.","year":"1993","unstructured":"Yu Y-Q, Xu D-B, Zhou X-D, Lu J-Z, Tang Z-Y, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer 1993; 71: 62-5.","journal-title":"Cancer"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.38.1.125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T13:19:56Z","timestamp":1765631996000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.38.1.125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1996,1,1]]},"published-print":{"date-parts":[[1996,1]]}},"alternative-id":["10.1136\/gut.38.1.125"],"URL":"https:\/\/doi.org\/10.1136\/gut.38.1.125","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}